A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy withn         Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706

Masahiro Fukuoka

首页> 外文期刊>Japanese Journal of Clinical Oncology >A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy withn Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706

【24h】

A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy withn Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706

机译：顺铂和伊立替康作为诱导化学疗法的II期研究，随后在不可切除的III期非小细胞肺癌中同时进行每周低剂量伊立替康的胸腔放疗：JCOG 9706

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Japanese Journal of Clinical Oncology》 |2011年第1期|p.25-31|共7页
作者
Masahiro Fukuoka;
展开▼
作者单位

Osaka City General Hospital, @%@, Hyogo Cancer Center, @%@, Osaka City General Hospital, @%@, Center for Cancer Control and Information Services, National Cancer Center, @%@, Kinki University School of Medicine, @%@, National Hospital Organization Kinki;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706. [J] . Takeda K, Negoro S, Tanaka M, Japanese journal of clinical oncology. . 2011,第1期

机译：在无法切除的III期非小细胞肺癌中，对顺铂和伊立替康作为诱导化疗的II期研究，随后是每周一次低剂量伊立替康的胸腔放疗，并伴有不可切除的III期非小细胞肺癌：JCOG 9706。
2. A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510. [J] . Fujii T, Kunikane H, Okamoto Japanese journal of clinical oncology. . 2009,第12期

机译：在无法切除的III期非小细胞肺癌中，对顺铂和伊立替康作为诱导化疗的II期研究，然后进行每日超低剂量卡铂加速超分割胸腔放疗：JCOG 9510。
3. A Phase II Study of Cisplatin and Irinotecan as Induction Chemotherapy Followed by Accelerated Hyperfractionated Thoracic Radiotherapy with Daily Low-dose Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer: JCOG 9510 [J] . Tomoki Fujii1 Hiroshi Kunikane1 Hiroaki Okamoto1 Koshiro Watanabe1 Hideo Kunitoh2 Kiyoshi Mori3 Akira Yokoyama4 Haruhiko Fukuda5 Tomohide Tamura6 and Nagahiro Saijo7 Japanese Journal of Clinical Oncology . 2009,第12期

机译：不可切除的III期非小细胞肺癌的顺铂和伊立替康作为诱导化学疗法，然后联合每日低剂量卡铂加速超分割胸腔放疗的II期研究：JCOG 9510
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan Carboplatin and Paclitaxel for Stage III Non-small Cell Lung Cancer [O] . Nicholas W. Choong, Everett E. Vokes, Daniel J. Haraf, -1

机译：依立替康卡铂和紫杉醇用于III期非小细胞肺癌的诱导化学疗法和同时放化疗的I期研究
7. A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy with Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706 [O] . K. Takeda, S. Negoro, M. Tanaka, 2010

机译：单铂和伊立替康作为感应化疗的II期研究，随后在不可切除，III阶段，非小细胞肺癌中伴随着每周低剂量伊替替康的伴随胸部放疗：Jcog 9706

A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy withn Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706

著录项

相似文献

相关主题

期刊订阅